Mar 9 2011
GeNOsys, Inc. (OTCBB:GNYS) announced that it has developed a group of nitric oxide producing products for topical use. The products support blood flow and collagen growth to injured tissue and support the healing process. The products will be available as a cream, gel or wash, depending on the desired application. Several patents have been filed related to the products and the procedures for their use. A patent application has also been filed for a nitric oxide producing product which may be used as a hand sterilizer.
"These products provide GeNOsys a significantly shorter pathway to revenue than that which can be expected from sales of our generator and nitric oxide producing medium," stated Mr. John W.R. Miller, Chairman of the Board of GeNOsys. "We are continuing work on the generator and expect to be able to provide you with updated information on that project in the near future. We have great expectations for the positive impact our generator will have for medical treatments. We expect the cash flow generated from our topical products will fund the commercialization of the generator. We are working to introduce these products into the marketplace at the earliest date possible and expect sales to be initiated no later than the third quarter of this year."